ArticleInternational journal of impotence research2026
Awareness of monkeypox virus among sexual medicine experts is low: a multi-institutional survey.
Article in International journal of impotence research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diagnostic Advances and Public Health Challenges for Monkeypox Virus: Clade-Specific Insight and the Urgent Need for Rapid Testing in Africa.Diagnostics (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An international outbreak of Monkeypox (mpox), a zoonotic orthopox virus, was confirmed by the World Health Organization in May 2022. The outbreak represented the first sustained community transmission of mpox beyond West or Central Africa, with speculated causes including declining smallpox vaccination rates, increased international travel, expanding populations, and sexual interactions. This study aimed to assess the understanding and recognition of mpox among sexual medicine experts including the identification of pertained genital lesions. An anonymous electronic survey was developed, addressing clinical manifestations, transmission, and management of mpox. It was distributed to attendees of the 23rd Joint Sexual Medicine Society of North America (SMSNA)/the 23rd International Society for Sexual Medicine (ISSM) conference, 2022. We collected data on various aspects of mpox awareness among the attendees, examining frequencies and percentages of responses. Of 960 conference attendees, 97 (10.1%) responded. Respondents exhibited limited knowledge regarding the recognition of mpox lesions (25.8%), likelihood of anogenital lesions (15.5%), and associated oral or proctitis bleeding (19.6 and 3.1% accuracy respectively). While 78.4% accurately identified contact as the primary transmission mode, knowledge regarding vaccination recommendations (42.3%) and median time from exposure to symptom onset (41.2%) was limited. The survey revealed substantial knowledge gaps among sexual medicine experts regarding mpox. Enhancing education and awareness initiatives is essential to improve preparedness for potential mpox outbreaks, enabling better patient care, and effective management within healthcare systems.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.